Astrazeneca Announces Approval of Calquence (Acalabrutinib) in Combination with Bendamustine and Rituximab in the US for the Treatment of Adult Patients
Astrazeneca Announces Approval of Calquence (Acalabrutinib) in Combination with Bendamustine and Rituximab in the US for the Treatment of Adult Patients
Jan 16, 2025
marketscreener.com
CALQUENCETM (acalabrutinib) Connections Video
1:08:02
CALQUENCETM (acalabrutinib) Connections Video
4K views11 months ago
YouTubeCALQUENCE (acalabrutinib)
Calquence Copay Card Details and Eligibility Explained
Calquence Copay Card Details and Eligibility Explained
Feb 10, 2025
cgaa.org
CALQUENCE® (acalabrutinib) Clinical Insights from a Real-World Patient with Treatment Naive CLL
31:15
CALQUENCE® (acalabrutinib) Clinical Insights from a Real-World Patient with Treatment Naive CLL
19.7K viewsSep 9, 2021
YouTubeCALQUENCE (acalabrutinib)
‼️Breaking News‼️ Thursday, November 21, 2019 | The FDA has approved a new CLL (Chronic Lymphocytic Leukemia) drug: Calquence. Want to learn more about this newly approved drug? Attend our Daily Wraps from ASH 2019 and our live CLL Ask-the Expert coming up early December. Register here: https://patientpower.info/events/ | Patient Power
1:37
‼️Breaking News‼️ Thursday, November 21, 2019 | The FDA has approved a new CLL (Chronic Lymphocytic Leukemia) drug: Calquence. Want to learn more about this newly approved drug? Attend our Daily Wraps from ASH 2019 and our live CLL Ask-the Expert coming up early December. Register here: https://patientpower.info/events/ | Patient Power
19.4K viewsNov 21, 2019
FacebookPatient Power
Dr Daniel Landau Presents CALQUENCE Long-Term and Pooled Cardiovascular Safety Data for CLL/SLL
27:13
Dr Daniel Landau Presents CALQUENCE Long-Term and Pooled Cardiovascular Safety Data for CLL/SLL
20.2K viewsJan 6, 2022
YouTubeCALQUENCE (acalabrutinib)
Calquence capsules (acalabrutinib) how to use: How and when to take it, Who can't take acalabrutinib
2:36
Calquence capsules (acalabrutinib) how to use: How and when to take it, Who can't take acalabrutinib
1.2K viewsMay 26, 2022
YouTubePharmacy Assistant
Dan’s Patient Testimonial Video
3:38
Dan’s Patient Testimonial Video
5.6K views11 months ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) Mechanism of Action (MOA) - Dr Pearson, MD
12:18
CALQUENCE® (acalabrutinib) Mechanism of Action (MOA) - Dr Pearson, MD
1.3K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
How CALQUENCE® (acalabrutinib) Works
2:18
How CALQUENCE® (acalabrutinib) Works
15.1K viewsOct 1, 2024
YouTubeCALQUENCE (acalabrutinib)
Steve’s Patient Testimonial Video
3:17
Steve’s Patient Testimonial Video
64.2K views11 months ago
YouTubeCALQUENCE (acalabrutinib)
AstraZeneca announces fixed-duration Calquence combo approved in US
AstraZeneca announces fixed-duration Calquence combo approved in US
1 month ago
marketscreener.com
CALQUENCE® (acalabrutinib) Patient Management & Adherence - Bradley, NP
16:38
CALQUENCE® (acalabrutinib) Patient Management & Adherence - Bradley, NP
1.5K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) Long-Term Data – Dr Brem, MD
16:09
CALQUENCE® (acalabrutinib) Long-Term Data – Dr Brem, MD
2.8K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) ELEVATE-RR and ASCEND Data - Dr Ma, MD
19:00
CALQUENCE® (acalabrutinib) ELEVATE-RR and ASCEND Data - Dr Ma, MD
2.6K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) ELEVATE-TN, Including 6-Year Median Follow-Up Data - Dr O'Brien, MD
22:41
CALQUENCE® (acalabrutinib) ELEVATE-TN, Including 6-Year Median Follow-Up Data - Dr O'Brien, MD
2K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) Safety Data -Dr Levy, MD
13:55
CALQUENCE® (acalabrutinib) Safety Data -Dr Levy, MD
1.2K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) MAIC of ASCEND and ALPINE -Dr Skarbnik, MD
19:59
CALQUENCE® (acalabrutinib) MAIC of ASCEND and ALPINE -Dr Skarbnik, MD
2.5K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) LY-004, Including 3-Year Follow Up Data- Dr Phillips, MD
17:55
CALQUENCE® (acalabrutinib) LY-004, Including 3-Year Follow Up Data- Dr Phillips, MD
4.5K views10 months ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) Perspectives: Dr Alexey Danilov, MD, PhD
15:35
CALQUENCE® (acalabrutinib) Perspectives: Dr Alexey Danilov, MD, PhD
1.8K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
CALQUENCE® (acalabrutinib) Pooled Safety Analysis - Dr Pinilla-Ibarz, MD
17:27
CALQUENCE® (acalabrutinib) Pooled Safety Analysis - Dr Pinilla-Ibarz, MD
3.1K views1 year ago
YouTubeCALQUENCE (acalabrutinib)
EHA25 Virtual Congress - CALQUENCE® Trial Results for Chronic Lymphocytic Leukemia
11:22
EHA25 Virtual Congress - CALQUENCE® Trial Results for Chronic Lymphocytic Leukemia
247 viewsJul 19, 2020
YouTubeHPR
Calquence Medication: Understanding its Benefits and Side Effects
10:07
Calquence Medication: Understanding its Benefits and Side Effects
804 viewsAug 30, 2023
YouTubeInevid
CALQUENCE TV Spot, 'Focus on the Things You're Loving'
CALQUENCE TV Spot, 'Focus on the Things You're Loving'
Oct 16, 2023
iSpot.tv
Phase II study of acalabrutinib, venetoclax, and obinutuzumab in CLL enriched for high-risk disease
2:12
Phase II study of acalabrutinib, venetoclax, and obinutuzumab in CLL enriched for high-risk disease
356 viewsDec 10, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
Calquence - Download Free 3D model by uniworks-47d3f8
Calquence - Download Free 3D model by uniworks-47d3f8
5 viewsNov 14, 2023
sketchfab.com
First-Line Venetoclax Combination Therapies for CLL - Dr. Barbara Eichhorst ASH 2023
12:05
First-Line Venetoclax Combination Therapies for CLL - Dr. Barbara Eichhorst ASH 2023
740 viewsAug 9, 2024
YouTubeCLL Society
New Options for Treatment-Resistant CLL - Dr. Meghan Thompson
5:08
New Options for Treatment-Resistant CLL - Dr. Meghan Thompson
857 viewsJan 8, 2025
YouTubeCLL Society
Understanding Mantle Cell Lymphoma (MCL)
4:11
Understanding Mantle Cell Lymphoma (MCL)
3.5K viewsJan 22, 2025
YouTubeThe Leukemia & Lymphoma Society of Canada
Combining pirtobrutinib, venetoclax, and obinutuzumab as first-line treatment for patients with CLL
1:24
Combining pirtobrutinib, venetoclax, and obinutuzumab as first-line treatment for patients with CLL
179 viewsDec 16, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more